CAS Investment Partners entered into an agreement with Cardlytics (CDLX)

Key Summary: On June 23, 2023, CAS Investment Partners (16.6%) expressed support for CEO Karim Temsamani, believing his expertise will drive needed change. They intend to engage with the board on enhancing stockholder value through improved performance, capital allocation, and board composition. On September 19, 2023, CAS entered into a Cooperation Agre…